CD38 and Miyoshi myopathy: Chatterjee et al. have shown that CD38 antibodies may directly stimulate T-cell mediated anti-tumor responses, while Marlein et al. showed that CD38-dependent tumor-derived tunneling nanotubes (TNT) are established between bone marrow stromal cells (BMSCs) and MM cells.